av Aina Rengmark | nov 15, 2023
BUSINESS OPPORTUNITY Leading scientists at the Oslo University Hospital have identified a unique biomarker in patients with basal-like breast cancer, which indicates a favorable prognosis. This group of patients largely represents those with triple-negative breast...
av Lise Rødsten | okt 20, 2021
BUSINESS OPPORTUNITY Scientists at Oslo University Hospital are developing a urine based test, addressing a major unmet need for non-invasive detection and monitoring of bladder cancer. Bladder cancer carries the highest per- lifetime, per-patient cost of any type of...
av Janncike Kristoffersen | aug 5, 2020
Business opportunity Leading scientists at the Cancer Registry of Norway and Oslo University Hospital have identified prediagnostic serum RNA biomarkers for early detection of lung cancer (LC). These biomarkers can be used in lung cancer screening of high-risk...
